Clinical Trials Browser

Unknown × Interventional × lanreotide × Clear all

NCT04427787 2021-09-05

LOLA

Phase 2 Unknown

Neuroendocrine Tumors

NCT03083210 2019-05-20

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

Phase 4 Unknown

Neuroendocrine Tumors

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT01731925 2017-01-31

SUNLAND

Phase 2 Unknown

Carcinoid Tumor, Neoplasm Metastasis